Carregant...
COUNTERPOINT: Access to transcatheter aortic valve replacement should not be limited to high-volume surgical centers
Transcatheter aortic valve replacement (TAVR) has transformed the treatment of aortic stenosis in high-risk older adults in Europe and has begun to do so in the United States. Recent Food and Drug Administration approval of the Edwards Lifesciences SAPIEN Transcatheter Heart Valve (Irvine, Calif) in...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3713505/ https://ncbi.nlm.nih.gov/pubmed/23679964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2013.02.079 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|